Basic Information
Fuisz is a family-owned enterprise with a wide range of technical interests and a long-standing, proven track record of innovation, including major (over $1 billion) products launched for large and specialty pharmaceutical companies as well as global consumer goods companies. Fuisz has contributed to the creation of the orally disintegrating tablet category, oral thin-film dosage forms, and has made significant contributions to drug controlled-release systems. Fuisz technologies are widely applied in drug delivery systems, opioid antagonism, and respiratory diagnostics.